mepolizumab 100 MG per 1 ML Auto-Injector
- RxCUI
- 2170990
- RxNorm name
- mepolizumab 100 MG per 1 ML Auto-Injector
- Display name
- mepolizumab 100 MG per 1 ML Auto-Injector
- Full name
- mepolizumab 100 MG per 1 ML Auto-Injector
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:30
Purple Book Biologic Products#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nucala | MEPOLIZUMAB | GlaxoSmithKline LLC | fefb887c-e4ac-431e-8893-e9d1a5a63fea | 2025-08-06 | Warnings, Adverse reactions | 2170990 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| fefb887c-e4ac-431e-8893-e9d1a5a63fea | mepolizumab 100 MG in 1 mL Auto-Injector [PSN] · 1 ML mepolizumab 100 MG/ML Auto-Injector [SCD] · mepolizumab 100 MG per 1 ML Auto-Injector [SY] | 3 | 24 | These highlights do not include all the information needed to use NUCALA safely and effectively. See full prescribing information for NUCALA. NUCALA (mepolizumab) for injection, for subcutaneous use NUCALA (mepolizumab) injection, for subcutaneous use Initial U.S. Approval: 2015 | 20250806 |